Abstract
In the work, new antibacterial compounds that combine sulfonamide and benzodioxane fragments in their framework were fabricated. Structures of the sulfonamide derivatives were determined by the IR, 1H NMR, 13C NMR, and EI-MS spectroscopy techniques. Antibacterial potential of these molecules was ascertained by biofilm inhibition study against Escherichia coli and Bacillus subtilis. The results revealed that two of the compounds were rather active inhibitors of these two pathogenic bacterial strains. According to the hemolytic study, most of the new molecules are mildly cytotoxic and hence might be used as safe antibacterial agents.
Similar content being viewed by others
REFERENCES
Stokes, S.S., Albert, R., Buurman, E.T., Andrews, B., Shapiro, A.B., Green, O.M., McKenzie, A.R., and Otterbein, L.R., Bioorg. Med. Chem. Lett., 2012, vol. 22, pp. 7019–7023.
Matsumoto, M., Kawamura, Y., Yasuda, Y., Tanimoto, T., Matsumoto, K., Yoshida, J., and Shoji, T., J. Antibiot., 1989, vol. 42, no. 10, pp. 1465–1469.
Shafi, S.S. and Radhakrishnan, T.R., Indian J. Heterocycl. Chem., 1995, vol. 5, pp. 133–138.
Chibale, K., Haupt, H., Kendrick, H., Yardley, V., Saravanamuthu, A., Fairlamb, A.H., and Croft, S.L., Bioorg. Med. Chem. Lett., 2001, vol. 11, no. 19, pp. 2655–2657.
Beale, JM. and Block, J.H., Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, Philadelphia: Lippincott Williams and Wilkins, 2011, 12th ed.
Labanauskas, L.K., Brukshtus, A.B., Gaidelis, P., Udrenaite, E.B., and Dauskhas, V.K., Pharm. Chem. J., 1999, vol. 33, no. 5, pp. 259–260.
Lukin, O., Gramlich, V., Kandre, R., Zhun, I., Felder, T., Schalley, C.A., and Dolgonos, G., J. Am. Chem. Soc., 2006, vol. 128, no. 27, pp. 8964–8974.
Cremlyn, R.J., An Introduction to Organosulfur Chemistry, New York: Wiley, 1996.
Ma, T., Fuld, A.D., Rigas, J.R., Hagey, A.E., Gordon, G.B., Dmitrovsky, E., and Dragnev, K.H., Chemotherapy, 2012, vol. 58, no. 4, pp. 321–329.
Abbasi, M.A., Hassan, M., Aziz-ur-Rehman, Siddiqui, S.Z., Shah, S.A.A., Raza, H., and Seo, Y., Peer J., 2018, vol. 4962, pp. 5–20.
Gonzalez, M.A., Gorman, D.B., Hamilton, C.T., and Ruth, G.A., Org. Process Res. Dev., 2008, vol. 12, no. 2, pp. 301–303.
Katte, T.A., Reekie, T.A., Werry, E.L., Jorgensen, W.T., Boyd, R., Wong, E.C.N., Gulliver, D.W., Connor, M., and Kassiou, M., Eur. J. Med. Chem., 2017, vol. 136, pp. 330–333.
Ahmed, B., Khan, S.A., and Alam, T., Pharmazie, 2003, vol. 58, no. 3, pp. 173–176.
Vazquez, M.T., Rosell, G., and Pujol, M.D., Eur. J. Med. Chem., 1997, vol. 32, no. 6, pp. 529–534.
Sun, J., Yang, Y.S., Li, W., Zhang, Y.B., Wang, X.L., Tang, J.F., and Zhu, H.L., Bioorg. Med. Chem. Lett., 2011, vol. 21, no. 20, pp. 6116–6121.
Abbasi, M.A., Massod, M., Aziz-ur-Rehman, Siddiqui, S.Z., Fatima, A., Shahid, M., Fatima, H., and Khan, K.M.,J. Chem. Soc. Pak., 2017, vol. 39, no. 6, pp. 999–1005.
Davis-Searles, P.R., Nakanishi, Y., Kim, N.C., Graf, T.N., Oberlies, N.H., and Wani, M.C., Cancer Res., 2005, vol. 65, no. 10, pp. 4448–4457.
Irshad, M., Abbasi, M.A., Aziz-ur-Rehman, Siddiqui, S.Z., Ashraf, M., Ejaz, S.A., Lodhi, M.A., and Jamal, S.B., J. Chem. Soc. Pak., 2014, vol. 36, no. 4, pp. 660–673.
Abbasi, M.A., Tariq, S., Aziz-ur-Rehman, Siddiqui, S.Z., Ahmad, I., Malik, R., and Shah S.A.A., Russ. J. Bioorg. Chem., 2016, vol. 42, no. 2, pp. 198–209.
Abbasi, M.A., Farani, S.K., Aziz-ur-Rehman, Siddiqui, S.Z., Ahmad, I., Malik, R., Ashraf, M., and Qurat-ul-Ain., Pharm. Chem. J., 2017, vol. 51, no. 3, pp. 193–199.
Stepanovic, S., Vukovic, D., Dakic, I., Savic, B., and Svabic-Vlahovic, M., J. Microb. Methods, 2000, vol. 40, no. 2, pp.175–179.
Sharma, P. and Sharma, J.D., J. Ethnopharmacol., 2001, vol. 74, pp. 239–234.
ACKNOWLEDGMENTS
The authors are thankful to Higher Education Commission of Pakistan for the financial support for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any studies involving human participants performed by any of the authors and does not contain any studies involving animals performed by any of the authors.
Conflict of Interests
The authors declare that they have no conflicts of interest.
Additional information
Corresponding author: e-mail: abbasi@gcu.edu.pk.
Rights and permissions
About this article
Cite this article
Muhammad A. Abbasi, Irshad, M., Aziz-ur-Rehman et al. Bacterial Biofilm Inhibition, Hemolytic Activity, and Structure–Activity Relationship of N-(2,3-Dihydro-1,4-Benzodioxin-6-yl)-4-Nitro-N-(Substituted-Benzyl)benzenesulfonamides. Russ J Bioorg Chem 46, 223–234 (2020). https://doi.org/10.1134/S1068162020020028
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162020020028